(Q34568550)

3 August 2017

1 reference

title

Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance (English)

1 reference

3 August 2017

1 reference

Michael H Davidson

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

American Journal of Cardiology

3 August 2017

published in

1 reference

3 August 2017

volume

89

1 reference

3 August 2017

issue

5A

1 reference

3 August 2017

page(s)

8C-20C; discussion 20C-22C

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

Prediction of Coronary Heart Disease Using Risk Factor Categories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

Pharmaceutical care services and results in project ImPACT: hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902223-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02223-3

1 reference

3 August 2017

1 reference